Target Global and One Peak Partners have taken part in a €15m series-D funding round for Warsaw-based medical appointments software company DocPlanner.
Existing investor Enern Investments led the funding round, following which DocPlanner will invest in new offices in Brazil and Mexico. The company will also invest in marketing activity across southern Europe and Latin America, and in the development of new services for doctors beyond its existing focus on calendar management.
The latest funding round brings the total amount raised by the startup to €46m and comes just 11 months after it announced a merger with its Spanish competitor Doctoralia. According to a statement, DocPlanner is open to the possibility of making additional bolt-on investments.
According to unquote" data, DocPlanner first raised VC backing in 2012, when it took a $1m injection from Point Nine Capital, Piton Capital and RTA Ventures.
In September the following year, it raised a $3m series-A round and topped it up with a $10m series-B in May 2015, led by the European Bank for Reconstruction and Development (EBRD).
Target Global then led a €20m series-C funding round for DocPlanner in June 2016, alongside EBRD and Enern Investments.
Founded in 2010, DocPlanner is an online doctor appointment booking system.
The company is headquartered in Warsaw and operates across 25 countries, claiming more than eight million monthly users. DocPlanner employs 300 people, up from 142 at the time of its most recent funding round in June 2016, and has additional offices in Barcelona, Istanbul and Rome.
One Peak Partners – Humbert de Liedekerke (managing partner).
DocPlanner – Mariusz Gralewski (CEO).
Fund, which has already been invested in at least one transaction, has a €1bn target
Pechel, via Pechel IV, and the co-investment team of Omnes back the French IT services firm
Connection Capital provided £6.7m to support the buyout of the business in 2017
Temasek previously led a £7m investment for the technology developer in 2016